Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.

Goricar, Katja; Kovac, Viljem; Franko, Alenka; Dodic-Fikfak, Metoda; Dolzan, Vita

Goricar, Katja; Kovac, Viljem; Franko, Alenka; Dodic-Fikfak, Metoda; Dolzan, Vita.

Afiliação

Goricar K; Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Kovac V; Institute of Oncology Ljubljana, SI-1000 Ljubljana, Slovenia.
Franko A; Clinical Institute of Occupational Medicine, University Medical Center Ljubljana, SI-1000 Ljubljana, Slovenia.
Dodic-Fikfak M; Clinical Institute of Occupational Medicine, University Medical Center Ljubljana, SI-1000 Ljubljana, Slovenia.
Dolzan V; Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Dis Markers ; 2015: 316739, 2015.

Article em En | MEDLINE | ID: mdl-26451067

Assuntos

Biomarcadores Tumorais/sangue; Proteínas Inibidoras de Apoptose/sangue; Mesotelioma/sangue; Idoso; Feminino; Humanos; Masculino; Mesotelioma/tratamento farmacológico; Mesotelioma/patologia; Pessoa de Meia-Idade; Survivina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas Inibidoras de Apoptose / Mesotelioma Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Dis Markers Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google